Physician

Anca D Pacuraru, D.O.

According to 2025 Medicare claims, Anca Pacuraru, D.O. (NPI: 1669407227) practices ophthalmology in the Abilene, TX market, with the plurality of this provider's patient population coming from Taylor, TX. This provider's primary affiliated billing organization is ABILENE PREMIER EYE CARE, PLLC (NPI: 1669814919; TIN: 463217249) and primary practice location at 79605-6805. Pacuraru is affiliated with the Main Street Rural Health Magnolia ACO LLC (ACO ID: A5400), participating under the MSSP model.

Pacuraru's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 856 traditional Medicare patients, billed 4,084 HCPCS/CPT codes, and received $271,966 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 5,556 prescription claims across 815 beneficiaries totaling $775,295 in drug costs, led by Xiidra (Lifitegrast). 2017 DME data shows 11 claims. Open Payments data shows 23 records totaling $609. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $229,586 to $775,295. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	582	2,642	$179,096
2016	639	2,885	$234,900
2017	659	3,132	$265,681
2018	695	3,111	$243,972
2019	695	3,241	$250,439
2020	630	2,853	$195,516
2021	791	3,984	$291,309
2022	873	4,039	$266,000
2023	882	4,038	$265,044
2024	856	4,084	$271,966

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	346	2,031	$229,586
2016	420	2,371	$291,146
2017	478	2,821	$395,018
2018	505	2,940	$458,981
2019	541	3,115	$476,590
2020	566	3,475	$587,392
2021	680	3,906	$651,123
2022	743	4,430	$808,443
2023	759	4,765	$729,516
2024	815	5,556	$775,295

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	11	11	$421
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	651	651	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	490	661	$63
92083	Exam of visual field with extended testing	335	361	$45
92250	Photography of the retina	675	677	$26
92133	Imaging of optic nerve	390	466	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xiidra	Lifitegrast	172	6,765	$148,528
Restasis	Cyclosporine	174	7,515	$138,977
Lumigan	Bimatoprost	278	9,173	$81,360
Miebo	Perfluorohexyloctane/Pf	47	2,071	$42,688
Combigan	Brimonidine Tartrate/Timolol	116	4,509	$32,897

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$609	Bausch & Lomb Americas Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anca D. Pacuraru, D.O.?

Tedicare shows public-source Medicare data for Anca D. Pacuraru, D.O. (NPI 1669407227), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anca D. Pacuraru, D.O. have ACO affiliation data?

Anca D. Pacuraru, D.O. is shown with ACO affiliation data for Main Street Rural Health Magnolia ACO LLC (MSSP, ACO ID A5400).

What billing organization is linked to Anca D. Pacuraru, D.O.?

Anca D. Pacuraru, D.O. is linked to ABILENE PREMIER EYE CARE, PLLC (billing NPI 1669814919) in the available physician profile data.

Does Anca D. Pacuraru, D.O. have Open Payments data?

Anca D. Pacuraru, D.O. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.